Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
besifloxacin (besivance) (1 trial)
erythromycin (ilosone) (1 trial)
Blepharitis (Phase 4)
Trials (1 total)
Trial APIs (2 total)